ReviewLeukemia2025

Challenges determining the best target duration of deep molecular response after which to attempt achieving therapy-free remission in chronic myeloid leukaemia.

Xiaowen Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.